 | Alexander L. Weis, PhD
Chairman, CEO & President - Co-founder of ILEX Oncology
- Founder of Lipitek, worked with Vector Therapeutics, Sterling Winthrop, Weizmann Institute, CTRC
- Fellow of the Royal Society of Chemistry
- South Texas Entrepreneur of the Year in 1996
- 20+ years in bio-pharmaceutical industry; over 60 publications and 28 patents
|  | J. Michael Edwards, MBA, CPA
Chief Financial Officer - PricewaterhouseCoopers, US Global Investors, ILEX Oncology, BioNumerik
- 15+ years experience in finance and accounting
|  | Corey Levenson, PhD
Chief Technical Officer - ILEX Oncology, Roche Molecular Systems, Cetus Corporation, USCF
- 25+ years in bio-pharmaceutical industry; 25 publications, 16 US patents
|  | Michael Moloney, MBA
Director of Program Management - CALGB, Duke University, BioNumerik Pharmaceuticals
- 20+ years experience in drug development and IT
|  | J. Kay Noel, PhD
Director of Regulatory Affairs - Axiom Pharmaceuticals, Cetus Corporation, Alpha Therapeutics, Abbott Labs
- 25+ years experience in bio-pharmaceuticals and regulatory affairs
|
|
